Skip to content
topiroxostat

Structure via PubChem · Public domain (PubChem)

EntityQ15725832· pop 5· linked from 204 articles

topiroxostat

Sign in to save

Also known as C13H8N6, 4-(5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl)pyridine-2-carbonitrile

Topiroxostat (INN; trade names Topiloric, Uriadec) is a drug for the treatment of gout and hyperuricemia. It was approved for use in Japan in June 2013.

In the Vinony graph

Vinony's link graph records 204 inbound references to topiroxostat, and connects out to adenosine receptor, inositol and oxypurinol.

It sits within the topics Chemical pages without DrugBank identifier, Drugs not assigned an ATC code and Drugs with non-standard legal status.

Vinony links it to 5 Wikipedia language editions.

Chemical data

Formula
C13H8N6
Molecular weight
248.24 g/mol
IUPAC name
4-(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)pyridine-2-carbonitrile
SMILES
C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N
InChIKey
UBVZQGOVTLIHLH-UHFFFAOYSA-N
XLogP
1.2
Polar surface area
91.1 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule
Indications
diabetic nephropathy, hyperuricemia

via ChEMBL · EBI

Wikidata facts

Mass
248.081
Show 3 more facts
chemical formula
C₁₃H₈N₆
canonical SMILES
C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N
Sources (3)

via Wikidata · CC0

~1 min read

Encyclopedic overview

1 sections
Contents
  • References

Topiroxostat (INN; trade names Topiloric, Uriadec) is a drug for the treatment of gout and hyperuricemia. It was approved for use in Japan in June 2013.

Topiroxostat is a xanthine oxidase inhibitor which reduces serum urate levels.

Excerpted from Wikipedia’s “topiroxostat” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0

Connections

Categories